678 results on '"Masuda, Noriyuki"'
Search Results
2. Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320)
3. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
4. Modulation of urinary frequency via type 1 lysophosphatidic acid receptors: Effect of the novel antagonist ASP6432 in conscious rats
5. Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib
6. Effect of ASP2205 fumarate, a novel 5-HT2C receptor agonist, on urethral closure function in rats
7. ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction
8. Amrubicin
9. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
10. Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers
11. Aminophylline increases respiratory muscle activity during hypercapnia in humans
12. Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
13. Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer
14. Amrubicin
15. Synchronization Between Cardiac and Respiratory Rhythms in Healthy Subjects and Patients
16. Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells
17. The role of prophylactic cranial irradiation for patients with small-cell lung cancer
18. Intratesticular Bradykinin Involvement in Rat Testicular Pain Models
19. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016
20. Open Architecture Test System: System Architecture and Design.
21. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma
22. Novel effect of 2-aminoethoxydiphenylborate through inhibition of calcium sensitization induced by Rho kinase activation in human detrusor smooth muscle
23. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma
24. Physiological Roles of Bradykinin and Involvement of Bradykinin B2 Receptor in Urethral Function in Humans and Animals
25. Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
26. Amrubicin
27. Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
28. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung
29. Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer
30. Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
31. Muscarinic M3 positive allosteric modulator ASP8302 enhances bladder contraction and improves voiding dysfunction in rats
32. Architecture and design of an open ATE to incubate the development of third-party instruments.
33. Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation
34. Effect of Selective Prostaglandin E2 EP2 Receptor Agonist CP-533,536 on Voiding Efficiency in Rats with Midodrine-Induced Functional Urethral Obstruction
35. Study on Physiological Roles of Stimulation of Prostaglandin E2 Receptor Subtype EP2 in Urethral Function in Rats
36. Induction of Bladder Overactivity by Nerve Growth Factor in Testes in Rats: Possible Neural Crosstalk Between the Testes and Urinary Bladder
37. Actions of cAMP on calcium sensitization in human detrusor smooth muscle contraction
38. Phase I and Pharmacologic Study of Weekly Bolus Topotecan for Advanced Non–Small-Cell Lung Cancer
39. Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502
40. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
41. Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expiration
42. Gold cleaning methods for electrochemical detection applications
43. Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys
44. Amrubicin
45. Potentiation of Muscarinic M3Receptor Activation through a New Allosteric Site with a Novel Positive Allosteric Modulator ASP8302
46. A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy
47. Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer
48. Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
49. Two Types of Cation Channel Activated by Stimulation of Muscarinic Receptors in Guinea-Pig Urinary Bladder Smooth Muscle
50. The role of nitric oxide in reducing deformability of Lewis lung tumor cell stimulated by inflammatory cytokines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.